gabapentin and alprazolam

gabapentin has been researched along with alprazolam in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's8 (40.00)29.6817
2010's8 (40.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jaiswal, S; Raja Ayyannan, S; Tiwari, V; Uniyal, A1
Matthews, J; Pollack, MH; Scott, EL1
Jefferson, JW1
Campbell, B; Crockford, D; White, WD1
Luggen, AS1
Dalal, MA; Himmerich, H; Müller, MB; Nickel, T1
Gironell, A1
Struble, LM1
Artoni, A; Bergamaschini, L; Damanti, S; Lucchi, T; Mannucci, PM; Mari, D1
Orlando, JM1
Acton, EK; Bilker, WB; Brensinger, CM; Chen, C; Chung, SP; Dawwas, GK; Dublin, S; Hennessy, S; Horn, JR; Leonard, CE; Miano, TA; Pham Nguyen, TP; Soprano, SE1
Guo, D; Kossintseva, I; Zloty, DM1

Reviews

3 review(s) available for gabapentin and alprazolam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Therapeutical strategies for essential tremor].
    Medicina clinica, 2007, Nov-03, Volume: 129, Issue:16

    Topics: Adult; Aged; Alprazolam; Amines; Antipsychotic Agents; Botulinum Toxins, Type A; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Deep Brain Stimulation; Essential Tremor; Fructose; Gabapentin; gamma-Aminobutyric Acid; Head Movements; Humans; Middle Aged; Primidone; Propranolol; Severity of Illness Index; Thalamus; Topiramate; Tranquilizing Agents; Voice Disorders

2007
Tremors: learning to stop the shakes.
    The Nurse practitioner, 2010, Volume: 35, Issue:6

    Topics: Adrenergic beta-Antagonists; Alprazolam; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Learning; Propranolol; Self Efficacy; Theophylline; Tremor; Vasodilator Agents

2010

Trials

1 trial(s) available for gabapentin and alprazolam

ArticleYear
Efficacy and Safety of Anxiolytics in Mohs Micrographic Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2023, 11-01, Volume: 49, Issue:11

    Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Diazepam; Double-Blind Method; Gabapentin; Humans; Lorazepam; Melatonin; Mohs Surgery; Pregabalin

2023

Other Studies

16 other study(ies) available for gabapentin and alprazolam

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2011
Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
    Bioorganic & medicinal chemistry, 2022, 04-15, Volume: 60

    Topics: Amidohydrolases; Analgesics; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Monoacylglycerol Lipases; Neuralgia; Semicarbazones

2022
Gabapentin as a potential treatment for anxiety disorders.
    The American journal of psychiatry, 1998, Volume: 155, Issue:7

    Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders

1998
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 1

    Topics: Acetates; Alprazolam; Amines; Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Clonazepam; Cyclohexanecarboxylic Acids; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Phobic Disorders; Placebos; Pregabalin; Treatment Outcome; Valproic Acid

2001
Gabapentin use in benzodiazepine dependence and detoxification.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:3

    Topics: Acetates; Alprazolam; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Substance-Related Disorders; Treatment Outcome

2001
Essential tremor in the older adult: coping with primary symptoms.
    Advance for nurse practitioners, 2004, Volume: 12, Issue:9

    Topics: Acetates; Adaptation, Psychological; Adrenergic beta-Antagonists; Aged; Alprazolam; Amines; Anticonvulsants; Antiparkinson Agents; Botulinum Toxins, Type A; Cyclohexanecarboxylic Acids; Essential Tremor; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuromuscular Agents; Primidone; Propranolol; Severity of Illness Index

2004
[Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
    Psychiatrische Praxis, 2007, Volume: 34, Issue:2

    Topics: Aged; Alprazolam; Amines; Antimanic Agents; Benzodiazepines; Carbamazepine; Chemical and Drug Induced Liver Injury; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Liver Function Tests; Panic Disorder; Substance Withdrawal Syndrome

2007
A thrombotic storm.
    Internal and emergency medicine, 2017, Volume: 12, Issue:1

    Topics: Aged; Alprazolam; Amines; Amputation, Surgical; Atorvastatin; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Thrombophilia; Ticlopidine; Venous Insufficiency; Venous Thrombosis

2017
Animal Behavior Case of the Month.
    Journal of the American Veterinary Medical Association, 2017, 11-01, Volume: 251, Issue:9

    Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diazepam; Dog Diseases; Dogs; Fear; Fluoxetine; Gabapentin; Male; Noise; Paroxetine; Phobic Disorders

2017
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signals.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:11

    Topics: Aged; Alprazolam; Diclofenac; Drug Interactions; Gabapentin; Humans; Medicare; Neuromuscular Agents; Omeprazole; United States

2022